BioSpace News Archive

Drug Development

Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002

Zhaoke Ophthalmology Pharmaceutical Ltd. is pleased to announce that the first patient has completed three year enrollment in the Phase III CHAMP study carried out by its partner, Nevakar Inc.

November 12, 2020
·
4 min read
Evotec Expands Oxfordshire Site into a Fully-Integrated R&D Centre Named ‘Dorothy Crowfoot Hodgkin Campus’

Evotec SE announced the expansion of the Company’s existing campus based at Milton Park in Abingdon, Oxfordshire, UK, into a major, fully-integrated, co-located discovery and development centre to be named Dorothy Crowfoot Hodgkin Campus.

November 12, 2020
·
5 min read
Pharm Country

CytoSorbents to Present at the Jefferies Virtual London Healthcare Conference

CytoSorbents Corporation announced that the Company will present an overview of the company at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020 and meet with investors in 1x1 meetings throughout the day.

November 12, 2020
·
5 min read
Business

Ultimovacs Announces Third Quarter 2020 Result Presentation

Ultimovacs ASA, a pharmaceutical company developing novel immunotherapies against cancer, announces its third quarter 2020 results

November 12, 2020
·
3 min read
Drug Development

NANOBIOTIX Announces Positive New Pre-clinical Data Suggesting Radioenhancer NBTXR3 Could Have a Significant Impact in Immunotherapy

NANOBOTIX, a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced positive new in vivo pre-clinical data from two studies at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting.

November 12, 2020
·
9 min read
Business

Quercis Pharma Appoints Philippe Douste-Blazy, M.D. to Board of Directors

Former French Minister of Health, Under-Secretary General of the United Nations and Chairman of UNITAID Brings Global Healthcare Expertise

November 12, 2020
·
3 min read
Business

ONK Therapeutics Opens US R&D Operations and Appoints Head of R&D, USA

ONK Therapeutics, Inc. formed, to facilitate the expansion of operations in the USA, alongside its growing hub in Galway, Ireland

November 12, 2020
·
5 min read
NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis

NeoDynamics AB, announced that the Company joins in a research collaboration with the William Hunter Revisited research consortium to evaluate NeoNavia pulse biopsy system for joint tissue sampling in a new potential indication, osteoarthritis.

November 12, 2020
·
2 min read
Drug Development

AM-Pharma Announces Enrollment of the First Patient in REVIVAL Phase III Pivotal Trial in Patients with Sepsis-Associated Acute Kidney Injury

Trial to confirm potential of AM-Pharma’s recombinant alkaline phosphatase to reduce mortality, as demonstrated in the Phase II STOP-AKI study

November 12, 2020
·
6 min read
Medidata and Oxford University Innovation’s Clinical Outcomes Team Announce Addition of Gold Standard Questionnaires to eCOA Library

Medidata and its customers gain access to pre-configured, pre-approved questionnaires in multiple languages to support clinical study start-up, quality, and efficiency

November 12, 2020
·
5 min read